Biomarker and testing questions
Ask how prior treatment history and cancer subtype affect eligibility.
Second-opinion questions
Is this recommended because of cancer subtype, prior treatments, or lack of other targeted options?
Safety discussion reminder
Discuss blood count monitoring, diarrhea management, and official label warnings with the oncology team.
Official source links
- NCI cancer drug information (NCI)
- DailyMed label search (DailyMed)
- FDA label search (FDA)
- ClinicalTrials.gov search (ClinicalTrials.gov)